(Q43938849)

28 November 2017

0 references

Galantamine and behavior in Alzheimer disease: analysis of four trials (English)

1 reference

28 November 2017

0 references

S Kavanagh

1

1 reference

28 November 2017

M Gaudig

2

1 reference

28 November 2017

B Van Baelen

3

1 reference

28 November 2017

M Adami

4

1 reference

28 November 2017

A Delgado

5

1 reference

28 November 2017

C Guzman

6

1 reference

28 November 2017

E Jedenius

7

1 reference

28 November 2017

B Schäuble

8

1 reference

28 November 2017

language of work or name

English

0 references

publication date

26 May 2011

1 reference

Acta Neurologica Scandinavica

28 November 2017

published in

1 reference

28 November 2017

volume

124

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

302-308

1 reference

Mental disorders in the nursing home: another perspective.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

The spectrum of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Behavioral effects of current Alzheimer's disease treatments: a descriptive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Impaired awareness, behavior disturbance, and caregiver burden in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

The incremental effect of dementia-related problem behaviors on the time to nursing home placement in poor, frail, demented older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Patient and caregiver characteristics and nursing home placement in patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Antipsychotic drug use and mortality in older adults with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Galantamine treatment of vascular dementia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Decreased initiation of usual activities in people with mild-to-moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Analyses of mortality risk in patients with dementia treated with galantamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

A systematic review of the association between the Behavioral and Psychological Symptoms of Dementia and burden of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2011.01525.X

10.1111/J.1600-0404.2011.01525.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference